US · Healthcare

Genflow Biosciences plc (GENFF)

Biotechnology

Genflow Biosciences plc (GENFF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for GENFF

P/E ratio

18.00

Genflow Biosciences plc (GENFF) — FAQ

What is GENFF's P/E ratio?

The price-to-earnings (P/E) ratio for Genflow Biosciences plc (GENFF) is 18.00 (data as of 2026-03-24).

Does Genflow Biosciences plc pay a dividend?

Dividend yield is not available in the current snapshot for Genflow Biosciences plc (GENFF). Check the MyAverix Finance app for the latest dividend data.

What sector is Genflow Biosciences plc in?

Genflow Biosciences plc (GENFF) is classified in the Healthcare sector (Biotechnology industry).

What exchange is GENFF listed on?

GENFF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)